216 related articles for article (PubMed ID: 20636993)
41. Adverse reactions to injectable soft tissue permanent fillers.
Christensen L; Breiting V; Janssen M; Vuust J; Hogdall E
Aesthetic Plast Surg; 2005; 29(1):34-48. PubMed ID: 15759096
[TBL] [Abstract][Full Text] [Related]
42. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients.
Wiest LG; Stolz W; Schroeder JA
Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764
[TBL] [Abstract][Full Text] [Related]
43. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers.
Redbord KP; Busso M; Hanke CW
Dermatol Ther; 2011; 24(1):71-81. PubMed ID: 21276160
[TBL] [Abstract][Full Text] [Related]
44. Human histology and persistence of various injectable filler substances for soft tissue augmentation.
Lemperle G; Morhenn V; Charrier U
Aesthetic Plast Surg; 2003; 27(5):354-66; discussion 367. PubMed ID: 14648064
[TBL] [Abstract][Full Text] [Related]
45. Soft tissue augmentation: nonsurgical approaches to treatment of the mid and lower facial regions.
Busso M
Dermatol Nurs; 2008 Jun; 20(3):211-4, 217-9. PubMed ID: 18649706
[TBL] [Abstract][Full Text] [Related]
46. [Granulomatous reactions from aesthetic dermal micro-implants].
Rongioletti F
Ann Dermatol Venereol; 2008 Jan; 135(1 Pt 2):1S59-65. PubMed ID: 18442665
[TBL] [Abstract][Full Text] [Related]
47. Use of high-frequency ultrasound in the assessment of injectable dermal fillers.
Young SR; Bolton PA; Downie J
Skin Res Technol; 2008 Aug; 14(3):320-3. PubMed ID: 19159378
[TBL] [Abstract][Full Text] [Related]
48. The Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds: A Multicenter, Randomized Clinical Study.
Choi WJ; Han SW; Kim JE; Kim HW; Kim MB; Kang H
Aesthetic Plast Surg; 2015 Dec; 39(6):953-62. PubMed ID: 26493557
[TBL] [Abstract][Full Text] [Related]
49. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules.
Narins RS; Dayan SH; Brandt FS; Baldwin EK
Dermatol Surg; 2008 Jun; 34 Suppl 1():S2-8; discussion S8. PubMed ID: 18547177
[TBL] [Abstract][Full Text] [Related]
50. Characterization of physical properties and histologic evaluation of injectable Dermicol-p35 porcine-collagen dermal filler.
Lorenc ZP; Nir E; Azachi M
Plast Reconstr Surg; 2010 Jun; 125(6):1805-1813. PubMed ID: 20517106
[TBL] [Abstract][Full Text] [Related]
51. Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler.
Fernández-Cossío S; Castaño-Oreja MT
Plast Reconstr Surg; 2006 May; 117(6):1789-96. PubMed ID: 16651952
[TBL] [Abstract][Full Text] [Related]
52. Survey of future injectables.
Ellis DA; Makdessian AS; Brown DJ
Facial Plast Surg Clin North Am; 2001 Aug; 9(3):405-11. PubMed ID: 11457704
[TBL] [Abstract][Full Text] [Related]
53. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid.
Rossner M; Rossner F; Bachmann F; Wiest L; Rzany B
Dermatol Surg; 2009 Feb; 35 Suppl 1():367-74. PubMed ID: 19207327
[TBL] [Abstract][Full Text] [Related]
54. Recent trend in the choice of fillers and injection techniques in Asia: a questionnaire study based on expert opinion.
Lee SK; Kim HS
J Drugs Dermatol; 2014 Jan; 13(1):24-31. PubMed ID: 24385116
[TBL] [Abstract][Full Text] [Related]
55. Soft tissue augmentation.
Hirsch RJ; Cohen JL
Cutis; 2006 Sep; 78(3):165-72. PubMed ID: 17036659
[TBL] [Abstract][Full Text] [Related]
56. Understanding the anatomy when using dermal fillers enhances patient safety.
Hotta T
Plast Surg Nurs; 2006; 26(3):149-51. PubMed ID: 16990754
[No Abstract] [Full Text] [Related]
57. Complications of soft tissue augmentation.
Hirsch RJ; Stier M
J Drugs Dermatol; 2008 Sep; 7(9):841-5. PubMed ID: 19112797
[TBL] [Abstract][Full Text] [Related]
58. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
Emer J; Sundaram H
J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
[TBL] [Abstract][Full Text] [Related]
59. Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial.
Monheit GD; Campbell RM; Neugent H; Nelson CP; Prather CL; Bachtell N; Eng D; Holmdahl L
Dermatol Surg; 2010; 36(1):94-101. PubMed ID: 20002638
[TBL] [Abstract][Full Text] [Related]
60. Temporal fossa defects: techniques for injecting hyaluronic acid filler and complications after hyaluronic acid filler injection.
Juhász ML; Marmur ES
J Cosmet Dermatol; 2015 Sep; 14(3):254-9. PubMed ID: 26311237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
